Kenvue (Kenvue) Capital Expenditure : $-567.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Kenvue Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Kenvue's cash flow for capital expenditures for the three months ended in Mar. 2024 was $-153 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was $-567.00 Mil.

Kenvue Capital Expenditure Historical Data

The historical data trend for Kenvue's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kenvue Capital Expenditure Chart

Kenvue Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Capital Expenditure

-289.00

-229.00

-295.00

-375.00

-469.00

Kenvue Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Capital Expenditure	Get a 7-Day Free Trial								-55.00	-77.00	-114.00	-223.00	-153.00

Kenvue Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-567.00 Mil.

Kenvue (Kenvue) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kenvue Inc (NYSE:KVUE) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

J4D:Germany J4D:Germany J4D:Germany

Address

199 Grandview Road, Skillman, NJ, USA, 08558

Website

https://www.kenvue.com

Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Executives

Allison Richard E Jr	director	30 FRANK LLOYD WRIGHT DR, ANN ARBOR MI 48105
Seemantini Godbole	director	1000 LOWE'S BOULEVARD, MOORESVILLE NC 28117
Bing Xie	officer: Group President, Asia Pacific	199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Donna Lorenson	officer: Chief Corp Affairs Officer	199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Matthew Orlando	officer: General Counsel	199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Luani Alvarado	officer: Chief People Officer	199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Jan Meurer	officer: Chief Growth Officer	199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Carlton Lawson	officer: Group President, EMEA	199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Caroline Tillett	officer: Chief Scientific Officer	199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Bernardo Tavares	officer: Chief Tech & Data Officer	199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Tamara Franklin	director	107 STONE CLIFF ROAD, PRINCETON NJ 08540
Betsy D Holden	director	DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Kathy Widmer	officer: Group President, NALA	C/O ELIZABETH ARDEN, INC., 2400 S.W. 145 AVENUE, MIRAMAR FL 33027
Michael E Sneed	director	JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Joseph J Wolk	director	JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933